Your browser doesn't support javascript.
loading
Even after SARS-CoV-2 booster, there is increased COVID-19 breakthrough infection in patients with plasma cell disorders.
Fillmore, Nathanael R; La, Jennifer; Wu, Julie Tsu-Yu; Corrigan, June K; Branch-Elliman, Westyn; Monach, Paul; Brophy, Mary T; Do, Nhan V; Munshi, Nikhil C.
Afiliação
  • Fillmore NR; VA Boston Healthcare System, Boston, MA.
  • La J; Department of Medicine, Harvard Medical School, Boston, MA.
  • Wu JT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Corrigan JK; VA Boston Healthcare System, Boston, MA.
  • Branch-Elliman W; Department of Medicine, Harvard Medical School, Boston, MA.
  • Monach P; VA Palo Alto Healthcare System, Palo Alto, CA.
  • Brophy MT; Department of Medicine, Stanford University, Stanford, CA.
  • Do NV; VA Boston Healthcare System, Boston, MA.
  • Munshi NC; VA Boston Healthcare System, Boston, MA.
Blood Adv ; 7(21): 6767-6770, 2023 11 14.
Article em En | MEDLINE | ID: mdl-37647600
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article